Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Recruitment

Liftstream is an executive search recruitment company in the life sciences sector

Women Currently only 10% of Biotech Boards, Gender Study Shows

Authored by Karl Simpson In a new research study into gender diversity in biotech leadership, the findings convey a picture of significant male dominance in biotech boardroom. The research conducted by Liftstream, a specialist life sciences executive search practice, examined … Continue reading

Posted in Executive Appointments, Pharmaceutical business, Recruitment Market | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Bellicum Pharma announces $55m in Series C Funding for Cancer Trials

Authored by James Sheppard The Houston based biotechnology firm Bellicum Pharmaceuticals announced that it had raised $55m in Series C funding. The money will be used to expand ongoing clinical trials for the company’s two leading drug candidates in oncology. … Continue reading

Posted in M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , , , , , | Leave a comment

Loxo Oncology Expands Leadership Team

Authored by James Sheppard The New York based biopharmaceutical company Loxo Oncology announced that it had added several senior executives across the company to help the company expand and build the clinical pipeline and advance early drug development. The appointments … Continue reading

Posted in Orphan Drugs and Rare Diseases, Recruitment Market | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

5 Alternative Methods for assessing the potential of a new employer

Authored by Karl Simpson Below are some ideas for the contrarians among you who might assess a new job opportunity. These escape the traditional clichés and provoke you to think about why you might seek to assess jobs in a … Continue reading

Posted in Pharmaceutical business, Recruitment Market | Tagged , , , , , , , , , , | Leave a comment

Genocea Biosciences secures European expertise with CFO appointment

Authored by Karl Simpson A lack of European leadership talent is often cited by investors as a limiting factor for European biotechs. Well, seemingly they are making every success of things on the other side of the Atlantic Ocean, where … Continue reading

Posted in Pharmaceutical business, Recruitment Market | Tagged , , , , , , , , , , , , , , , , | Leave a comment

British ex-Glaxo executive joins Board of US biotech Zocere

Authored by Karl Simpson Zocere Inc. is based in New Mexico and is developing injectable neuroprotectant drugs to combat stroke and other neurological trauma. Zocere have announced the appointment of Dr. Adrian Hobden to their Board of Directors. Dr. Hobden … Continue reading

Posted in Executive Appointments, Orphan Drugs and Rare Diseases, Pharmaceutical business, Uncategorized | Tagged , , , , , , , , , , , , | Leave a comment

PTC Therapeutics appoints Chief Medical Officer and communicates CHMP conditional decision

Authored by Karl Simpson For patients living with Duchenne Muscular Dystrophy, last year offered great hope but also disappointment. The momentum was building in the development of exciting new therapies and they were looking forward to the promise of meaningful … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Shire expands rare disease reach with Viropharma Purchase

Authored by James Sheppard Shire has made its first significant acquisition since the arrival of new CEO, Flemming Ornskov. Shire announced that it had successfully acquired US based rare disease specialist Viropharma. Shire has agreed to pay $4.2bn for Viropharma … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

Osiris sells stem cell business in $100m deal

Authored by James Sheppard The US based biotechnology company Osiris Therapeutics has announced a $100m deal with Australian biotech Mesoblast for the company to buy its stem cell platform. The deal includes Osiris’s off the shelf stem cell product Prochymal. … Continue reading

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , | Leave a comment

immatics bags $46m for Phase III cancer vaccine

Authored by James Sheppard The German biotech company immatics, backed by biotech billionaire Dietmar Hopp, has secured a further $46m in series D funding for its cancer vaccine IMA901. The funding was provided by Hopp Biotech, Wellington Partners, MIG-advised funds … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap